Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway

Background: Pulmonary fibrosis (PF) is a terminal pathological change in a variety of lung diseases characterized by excessive deposition of extracellular matrix, for which effective treatment is lacking. Tangeretin (Tan), a flavonoid derived from citrus, has been shown to have a wide range of pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiang, Wei, Qian, Song, Ke, Wang, Youxin, Yang, Yuxin, Li, Miao, Yu, Jiaying, Su, Guangxu, Peng, Luyuan, Fu, Bendong, Yi, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540689/
https://www.ncbi.nlm.nih.gov/pubmed/37781713
http://dx.doi.org/10.3389/fphar.2023.1247800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540689/
https://www.ncbi.nlm.nih.gov/pubmed/37781713
http://dx.doi.org/10.3389/fphar.2023.1247800

Ejemplares similares